A growing body of research indicates that popular weight-loss drugs, such as Ozempic and Wegovy, may have additional benefits. These medications might help treat or even prevent certain types of cancer. This is an unexpected advantage linked with GLP-1s, a class of drugs now used by one-in-eight adults in the United States.
William Brangham reports on this new finding as part of his coverage for PBS News. Brangham is known for his work as an award-winning correspondent, producer, and substitute anchor for PBS News Hour. He also hosts the show Horizons from PBS.
Joe Biden’s Prostate Cancer Progression and Current Healthcare Insights 
Vibrio Vulnificus: A Deadly Threat in Coastal Waters 
The Journey of Annelise Camp: A Family’s Battle and Tragic Loss 
Understanding N95 Respirators: What You Need to Know 
Ethan Suplee’s Journey to Sustainable Weight Management 
MaineHealth Board Votes to Close Maternity Unit at Lincoln Hospital